Autolus Therapeutics Cash from Operations (TTM) Analysis

Autolus Therapeutics PLC (AUTL)

4.295 -0.18 (-4.13%) USD | NASDAQ | Apr 24, 12:45

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-145.59M
September 30, 2023	-135.32M
June 30, 2023	-127.04M
March 31, 2023	-119.70M
December 31, 2022	-112.31M
September 30, 2022	-106.90M
June 30, 2022	-109.74M
March 31, 2022	-115.55M
December 31, 2021	-117.86M

Date	Value
September 30, 2021	-136.43M
June 30, 2021	-140.75M
March 31, 2021	-131.07M
December 31, 2020	-117.76M
September 30, 2020	-123.30M
June 30, 2020	-108.72M
March 31, 2020	-99.00M
December 31, 2019	-101.48M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-145.59M

Minimum

Dec 2023

-99.00M

Maximum

Mar 2020

-120.50M

Average

-117.86M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks